Fig. 1: Pathophysiology of Fabry disease. | npj Cardiovascular Health

Fig. 1: Pathophysiology of Fabry disease.

From: Cardiac manifestations of Fabry disease

Fig. 1

Diagrammatic representation of the possible pathways between lysosomal storage and signs and symptoms of Fabry Disease. Adapted from Linhart79 and Pieroni et al.48. GB3 globotriaosylceramide, lyso-Gb3 lyso-globotriaosylceramide, VSMC vascular smooth muscle cells.

Back to article page